Page last updated: 2024-10-22

alendronate and Syndrome

alendronate has been researched along with Syndrome in 5 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Syndrome: A characteristic symptom complex.

Research Excerpts

ExcerptRelevanceReference
"The clinical presentation of Gorham's disease varies according to the organ of involvement."2.53Novel approach of treating Gorham-Stout disease in the humerus--Case report and review of literature. ( Al-Hussaini, M; Attili, A; Ellati, R; Haddad, H; Shehadeh, A, 2016)
"Hadju-Cheney syndrome is characterized by short stature, distinctive facies, and a slowly progressive skeletal dysplasia including acro-osteolysis."1.32Hadju-Cheney syndrome: response to therapy with bisphosphonates in two patients. ( Drake, WM; Hiorns, MP; Kendler, DL, 2003)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ellati, R1
Attili, A1
Haddad, H1
Al-Hussaini, M1
Shehadeh, A1
Moynihan, R1
Emad, Y1
Ragab, Y1
El-Shaarawy, N1
Rasker, JJ1
Drake, WM1
Hiorns, MP1
Kendler, DL1
Maffei, L1
Murata, Y1
Rochira, V1
Tubert, G1
Aranda, C1
Vazquez, M1
Clyne, CD1
Davis, S1
Simpson, ER1
Carani, C1

Reviews

2 reviews available for alendronate and Syndrome

ArticleYear
Novel approach of treating Gorham-Stout disease in the humerus--Case report and review of literature.
    European review for medical and pharmacological sciences, 2016, Volume: 20, Issue:3

    Topics: Adolescent; Alendronate; Bone Density Conservation Agents; Combined Modality Therapy; Fracture Fixat

2016
Transient osteoporosis of the hip, complete resolution after treatment with alendronate as observed by MRI description of eight cases and review of the literature.
    Clinical rheumatology, 2012, Volume: 31, Issue:11

    Topics: Alendronate; Bone Density Conservation Agents; Bone Marrow; Diphosphonates; Edema; Hip Joint; Humans

2012

Other Studies

3 other studies available for alendronate and Syndrome

ArticleYear
Battle over popular bone drug Fosamax bursts into court.
    BMJ (Clinical research ed.), 2009, Aug-06, Volume: 339

    Topics: Alendronate; Bone Density Conservation Agents; Drug Industry; Humans; Jaw Diseases; Legislation, Dru

2009
Hadju-Cheney syndrome: response to therapy with bisphosphonates in two patients.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2003, Volume: 18, Issue:1

    Topics: Acro-Osteolysis; Adult; Alendronate; Bone Density; Bone Diseases, Developmental; Bone Resorption; Fe

2003
Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment.
    The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:1

    Topics: Acanthosis Nigricans; Adult; Alendronate; Aromatase; Arteriosclerosis; Bone and Bones; Cryptorchidis

2004